Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy
PHASE2CompletedINTERVENTIONAL
Enrollment
44
Participants
Timeline
Start Date
May 31, 2003
Primary Completion Date
January 31, 2004
Conditions
Breast Cancer
Interventions
DRUG
gefitinib
Trial Locations (1)
1000
Institut Jules Bordet, Brussels
All Listed Sponsors
lead
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
NCT00066339 - Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy | Biotech Hunter | Biotech Hunter